APTARGROUP, INC. ATR 83.74
Health Care · NYSE · Data as of 2026-10-30
APTARGROUP, INC. (ATR) has delivered +5.4% annualized revenue growth, +7.2% earnings growth, and +5.0% dividend growth over 10 years of data. Ranked #60 of 1968 stocks overall and #8 of 260 in the Health Care sector by Steady Score.
About APTARGROUP, INC.
Company Overview
AptarGroup designs and manufactures dispensing, drug-delivery and sealing systems for pharmaceutical, beauty, personal-care, home-care, food and beverage products. Its portfolio includes pumps, aerosol valves, closures, elastomer components, injection and inhalation devices, active-material solutions and digital-health services. Customers use these components to protect formulations, control dosing and make packaged products convenient and reliable. Aptar serves major brands and healthcare manufacturers across markets worldwide.
Read more
Business Model & Revenue
Revenue comes from selling proprietary components and systems to consumer-products and healthcare manufacturers, often after joint development and customer qualification. Pharma products can have long development and regulatory cycles, supporting durable supply relationships once incorporated into an approved medicine or device. Beauty and Closures demand follows launches, consumer spending and packaging volumes. Aptar also earns tooling, development and service revenue connected with customer programs.
Key Facts & Market Position
Aptar reports three segments: Pharma, Beauty and Closures. Its competitive position rests on specialized design, material science, manufacturing quality and global production capacity. The Pharma segment serves prescription drugs, consumer health, injectables and digital health and carries particularly demanding quality requirements, while the other segments diversify the company across major consumer packaging markets.